scholarly journals Mild cognitive impairment in maintenance hemodialysis patients: a cross-sectional survey and cohort study

2018 ◽  
Vol Volume 14 ◽  
pp. 27-32 ◽  
Author(s):  
Xiaohua Pei ◽  
Shuyuan Lai ◽  
Xianglan He ◽  
Nakimera Pearl Masembe ◽  
Haichuan Yuan ◽  
...  
2017 ◽  
Vol 44 (2) ◽  
pp. 110-121
Author(s):  
Marijana Gulin ◽  
Dragan Klarić ◽  
Mario Ilić ◽  
Josipa Radić ◽  
Vedran Kovačić ◽  
...  

Aims: This study was aimed at comparing the incidence of arterial hypertension and blood pressure (BP) variance in hospital and out-of-hospital hemodialysis (HD) patients during HD sessions. Methods: A cross-sectional study was conducted for 1 week at all the HD centers in Dalmatia, Croatia. The pre-, intra-, and post-dialysis BP values were collected for 3 consecutive HD sessions per patient. Results: Of the 399 subjects, 73.9% were hypertensives, who showed higher interdialytic weight gain compared to the normotensives (2.58 vs. 2.40). Hospital and out-of-hospital HD patients received identical antihypertensive therapies, except that beta blockers were more frequently administered to out-of-hospital HD patients. Higher pre-, intra-, and post-dialysis BP values were recorded in patients at out-of-hospital HD centers. Conclusion: The differences in BP variability and antihypertensive therapies administered to hospital HD patients as compared to out-of-hospital HD patients may reflect differing approaches by the nephrologists at these centers.


2016 ◽  
Vol 04 (05) ◽  
pp. E589-E596 ◽  
Author(s):  
Naoki Hosoe ◽  
Shigeaki Matsukawa ◽  
Yoshihiko Kanno ◽  
Makoto Naganuma ◽  
Hiroyuki Imaeda ◽  
...  

2012 ◽  
Vol 59 (2) ◽  
pp. 249-257 ◽  
Author(s):  
Albert Power ◽  
Kakit Chan ◽  
Seema K. Singh ◽  
David Taube ◽  
Neill Duncan

Nutrients ◽  
2018 ◽  
Vol 10 (9) ◽  
pp. 1164 ◽  
Author(s):  
Chien-Lin Lu ◽  
Jia-Fwu Shyu ◽  
Chia-Chao Wu ◽  
Chi-Feng Hung ◽  
Min-Tser Liao ◽  
...  

Canonical Wnt (Wingless/Integrated) signaling is crucial in bone development and the Wnt ligand can promote osteoblast differentiation from mesenchymal progenitor cells. Calcitriol, an active vitamin D3, is used clinically for treatment of secondary hyperparathyroidism (SHPT) in chronic kidney disease (CKD) patients. The bone effects of calcitriol in SHPT remains uncertain. We hypothesized that calcitriol improves bone mass by suppressing osteoclast activity, and simultaneously promoting Wnt ligand secretion. We designed a cross-sectional study in maintenance hemodialysis patients to explore the effects of calcitriol on different bone turnover markers and specifically emphasized the Wnt 10b levels. Then, we explored the source of Wnt 10b secretion by using osteoclasts and osteoblasts treated with calcitriol in cell culture studies. Finally, we explored the effects of calcitriol on bone microarchitectures in CKD mice, using the 5/6 nephrectomy CKD animal model with analysis using micro-computed tomography. Calcitriol promoted the growth of both trabecular and cortical bones in the CKD mice. Wnt 10b and Procollagen 1 N-terminal Propeptide (P1NP) significantly increased, but Tartrate-resistant acid phosphatase 5b (Trap 5b) significantly decreased in the calcitriol-treated maintenance hemodialysis patients. Calcitriol enhanced Wnt 10b secretion from osteoclasts in a dose-dependent manner. Treatment of SHPT with calcitriol improved the bone anabolism by inhibiting osteoclasts and promoting osteoblasts that might be achieved by increasing the Wnt 10b level.


2012 ◽  
Vol 22 (6) ◽  
pp. 578-583 ◽  
Author(s):  
Denise Mafra ◽  
Cristiane Moraes ◽  
Viviane O. Leal ◽  
Najla E. Farage ◽  
Milena B. Stockler-Pinto ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document